efavirenz has been researched along with Acute Confusional Senile Dementia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Mast, N; Pikuleva, IA | 1 |
| Arnold, SE; Denker, J; Fortin, B; Koenig, A; Lerner, AJ; Mast, N; Maxfield, E; Pieper, AA; Pikuleva, IA; Raghupathy, S; Tatsuoka, C; Toth, ME; Trombetta, BA | 1 |
| van Lier, JE | 1 |
| Arakawa, H; Constans, J; Landreth, G; Li, Y; Mast, N; Maxfield, E; Pikuleva, IA; Saadane, A; Valencia-Olvera, A | 1 |
| Lam, M; Li, Y; Mast, N; Maxfield, E; Moon, J; Petrov, AM; Pikuleva, IA | 1 |
| Clark, M; Li, Y; Linger, M; Mast, N; Pikuleva, IA; Wiseman, J | 1 |
1 trial(s) available for efavirenz and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Cholesterol; Cholesterol 24-Hydroxylase; Humans; Pilot Projects | 2022 |
5 other study(ies) available for efavirenz and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Increased Acetylcholine Levels and Other Brain Effects in 5XFAD Mice after Treatment with 8,14-Dihydroxy Metabolite of Efavirenz.
Topics: Acetylcholine; Alkynes; Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzoxazines; Brain; Cholesterol; Cholesterol 24-Hydroxylase; Cyclopropanes; Disease Models, Animal; Female; Male; Mice | 2022 |
New Therapeutic Targets for Brain Function and Disease.
Topics: Alkynes; Alzheimer Disease; Animals; Benzoxazines; Brain; Cholesterol 24-Hydroxylase; Cyclopropanes; Cytochrome P-450 CYP3A Inducers; Humans | 2020 |
Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease.
Topics: Administration, Oral; Alkynes; Alzheimer Disease; Animals; Benzoxazines; Brain; Cholesterol; Cholesterol 24-Hydroxylase; Cyclopropanes; Disease Models, Animal; Female; Learning; Liver X Receptors; Male; Memory; Mice, Transgenic; Microglia; Neuroprotective Agents; Plaque, Amyloid; Transcriptome | 2017 |
CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice.
Topics: Alkynes; Alzheimer Disease; Animals; Benzoxazines; Brain; Cholesterol 24-Hydroxylase; Conditioning, Classical; Cyclopropanes; Disease Models, Animal; Enzyme Activation; Female; Male; Maze Learning; Mice; Nootropic Agents; Plaque, Amyloid | 2019 |
Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice.
Topics: Alkynes; Alzheimer Disease; Animals; Benzoxazines; Brain; Brain Chemistry; Cattle; Cholesterol; Cholesterol 24-Hydroxylase; Cyclopropanes; Enzyme Activation; Female; HIV Infections; Male; Mice; Models, Biological; Reverse Transcriptase Inhibitors; Steroid Hydroxylases | 2014 |